1843 Capital

1843 Capital is a venture firm with a public website, LinkedIn, and CB Insights footprint, but the input record is missing core diligence fields including HQ location, investor type, stages, healthcare sub-verticals, AI focus, and check size. That gap is honest and load-bearing: this profile cannot make sharp claims about positioning, stage focus, or healthcare exposure that the data does not support. Based on the public-source links alone, the firm appears to be a structured investment platform rather than a solo-angel vehicle, but founders should not treat that inference as confirmation of healthcare-investing activity, AI orientation, or check sizing. Until the underlying data fields are populated, founders considering 1843 Capital for a healthcare round should treat the firm as a research target rather than an outreach target: review the website to understand the stated focus, check CB Insights for investment history and sectoral concentration, scan LinkedIn for current team and recent activity, and confirm whether the firm is actively writing healthcare checks at the founder’s stage before committing time to a pitch. If after that initial research the firm appears to be a relevant fit, a LinkedIn-based outreach to a partner with a brief, specific framing of the company and the round size and structure is the appropriate next step. If the firm’s stated focus does not align with healthcare or with the founder’s stage, deprioritize and revisit only if the firm publicly signals an expansion into healthcare AI investing in the future.